News archive search

Search the Newsreel

Search stored headlines and summaries, then narrow the results by company, country, sector, industry, source or date.

Showing
1–36
Matches
64
Sources here
16
Companies here
2
Search results Stored financial headlines

Active search

64 matching headlines

Ticker or company: MEDNMain company stories
Clear
Latest

Simply Wall Street Earnings

Will Earnings Beat and Major Buybacks Change Pediatrix Medical Group's (MD) Narrative

Pediatrix Medical Group (MD) recently reported strong Q2 2026 results, with increased sales and net income, alongside significant share repurchases. These actions, particularly the buybacks, are supporting the company's per-share metrics amidst ongoing challenges like reimbursement and labor costs. The article suggests that while these positive developments are notable, investors should remain aware of potential sustained reimbursement pressures …

Pediatrix Medical Group (MD) awards 472-share equity grant to director

Pediatrix Medical Group (MD) director Shirley A. Weis was granted 472 restricted shares of common stock on August 12, 2026, under the company's 2008 Incentive Compensation Plan. These shares, valued at $26.50 each, will vest on May 7, 2027, and increase Weis's direct holdings …

MD main company
Sharemaestro market context Trend signal active 52 weeks +56.4% MD stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Search results

Matching headlines

External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.

Pediatrix Medical Group (MD) director receives 472-share restricted stock grant

John M. Starcher Jr., a director at Pediatrix Medical Group (MD), was granted 472 restricted shares of common stock on August 12, 2026. These shares, valued at $26.50 each, are part of the company's incentive compensation plan and will vest on May 7, 2027. …

MD main company
Sharemaestro market context Trend signal active 52 weeks +56.4% MD stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Pediatrix Medical Group (MD) director awarded 472 restricted shares and reports trust holdings

Pediatrix Medical Group director Thomas McEachin was granted 472 restricted shares of common stock on August 12, 2026, valued at $26.50 per share, under the company's incentive plan. These shares will vest on May 7, 2027. Following this transaction, his direct holdings increased to …

MD main company
Sharemaestro market context Trend signal active 52 weeks +56.4% MD stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Pediatrix Medical Group (MD) grants 472 restricted shares to director Sansone

Pediatrix Medical Group (MD) director Guy P. Sansone received an equity award of 472 restricted shares on August 12, 2026, priced at $26.50 per share. These shares, granted under the company's Second Amended and Restated 2008 Incentive Compensation Plan, will vest on May 7, …

MD main company
Sharemaestro market context Trend signal active 52 weeks +56.4% MD stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Pediatrix Medical Group, Inc. Stock 12‑Month Price Target Cut to $26, Implies 2% Downside

The average 12-month price target for Pediatrix Medical Group, Inc. (MD) stock has been lowered from $26.17 to $26 by 5 analysts, with a range of $21 to $28 per share. This new target suggests a potential 2% downside from the August 12 closing …

MD main company
Sharemaestro market context Trend signal active 52 weeks +56.4% MD stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Wasatch Advisors LP Boosts Stake in Pediatrix Medical Group, Inc. $MD

Wasatch Advisors LP increased its stake in Pediatrix Medical Group, Inc. (NYSE:MD) by 21.9% in the second quarter, holding 2.50 million shares valued at approximately $63.3 million. Institutional investors now own 97.71% of the company's stock, which recently reported strong quarterly earnings, beating revenue …

MD main company
Sharemaestro market context Trend signal active 52 weeks +56.4% MD stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Pediatrix Medical Group (MD) Q2 2026 Earnings Call Transcript

Image source: The Motley Fool. DATE Tuesday, Aug. 4, 2026 at 9:00 a.m. ET CALL PARTICIPANTS Chief Executive Officer - Mark Ordan Chief Financial Officer - Kasandra Rossi Full Conference Call Transcript Operator: Thank you for standing by. My name is Jordan, and I'll …

MD main company
Sharemaestro market context Trend signal active 52 weeks +56.4% MD stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Pediatrix Medical Group (MD) Stock Seems Undervalued While Its 89% Return Raises Questions

Pediatrix Medical Group (MD) has seen an 89% share price return over the past year, yet its stock appears undervalued based on several valuation metrics, including a P/E ratio significantly below the healthcare sector average. Despite a recent share price drop post-earnings, the company …

MD main company
Sharemaestro market context Trend signal active 52 weeks +56.4% MD stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Is Stronger Q2 2026 EPS From Operations Altering The Investment Case For Pediatrix Medical Group (MD)?

Pediatrix Medical Group (MD) reported stronger Q2 2026 results with increased sales and net income, leading to improved EPS from continuing operations. These results, along with the company's inclusion in Russell 2000 Defensive indexes, support its investment narrative of disciplined cost control in the …

MD main company
Sharemaestro market context Trend signal active 52 weeks +56.4% MD stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Sei Investments Co. Cuts Stock Holdings in Pediatrix Medical Group, Inc. $MD

Sei Investments Co. reduced its stake in Pediatrix Medical Group Inc. (NYSE:MD) by 19.3% in the first quarter, selling 37,564 shares and retaining 157,407 shares valued at $3.37 million. Despite institutional selling and buying from various firms, the company reported strong Q1 earnings of …

MD main company
Sharemaestro market context Trend signal active 52 weeks +56.4% MD stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Onemednet director Thomas Kosasa buys $1 million in shares By Investing.com

OneMedNet Corp. director and 10% owner Thomas Kosasa recently invested $1 million in the company, acquiring 1,449,275 shares at $0.69 each. This purchase increased his direct beneficial ownership to over 18.5 million shares. Separately, OneMedNet announced over $3 million in new bookings for 2026, …

ONMD main company
Sharemaestro market context Price below Trend Line 52 weeks +0.1% · Next-week setup negative 42.5% ONMD stored weekly price path from 22 Aug 2025 to 14 Aug 2026

OneMedNet (NASDAQ: ONMD) plans reverse stock split and adds 1M incentive shares

OneMedNet (NASDAQ: ONMD) is seeking stockholder approval for a reverse stock split at a ratio between 1-for-5 and 1-for-20 to regain compliance with Nasdaq's minimum bid price requirement. Additionally, the company plans to amend its 2022 Equity Incentive Plan to increase the share reserve …

ONMD main company
Sharemaestro market context Price below Trend Line 52 weeks +0.1% · Next-week setup negative 42.5% ONMD stored weekly price path from 22 Aug 2025 to 14 Aug 2026

OneMedNet (ONMD) insider invests $1,000,000 in new share subscription

OneMedNet Corp director and 10% owner Thomas Kosasa invested $1,000,000 in the company by purchasing 1,449,275 shares of common stock on July 30, 2026. The shares were acquired through a subscription agreement at $0.69 each, a price based on the volume-weighted average price for …

ONMD main company
Sharemaestro market context Price below Trend Line 52 weeks +0.1% · Next-week setup negative 42.5% ONMD stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Onemednet Corp (ONMD) Earnings Forecast: Future EPS & Revenue Growth Estimates

This article provides an earnings forecast for Onemednet Corp (ONMD), focusing on its future EPS and revenue growth estimates. It briefly mentions the stock's current market data, including its closing price and market cap. The content appears to be a stub or a placeholder …

ONMD main company
Sharemaestro market context Price below Trend Line 52 weeks +0.1% · Next-week setup negative 42.5% ONMD stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Price to earnings forward of OneMedNet Corp – NASDAQ:ONMD

This page provides financial information for OneMedNet Corp (NASDAQ: ONMD), specifically focusing on its forward price-to-earnings ratio. The content appears to be a snapshot from TradingView, displaying key financial metrics and offering tools for market analysis.

ONMD main company
Sharemaestro market context Price below Trend Line 52 weeks +0.1% · Next-week setup negative 42.5% ONMD stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Insiders At Pediatrix Medical Group Sold US$1.8m In Stock, Alluding To Potential Weakness

This article analyzes insider selling at Pediatrix Medical Group (NYSE:MD) totaling US$1.8m over the last year, particularly a large sale by the CEO, which could signal potential weakness in the company's future performance. Despite the stock price being down 23% in the past 12 …

MD main company
Sharemaestro market context Trend signal active 52 weeks +56.4% MD stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Pediatrix Q2 2026 earnings: Reimbursement gains offset volume declines

Pediatrix Medical Group (NYSE: MD) reported a 4.0% year-over-year increase in Q2 2026 net revenue to $487.8 million, driven by recent acquisitions and improved reimbursement rates, despite a decline in patient volumes. While diluted GAAP EPS rose to $0.49, higher operating costs led to …

MD main company
Sharemaestro market context Trend signal active 52 weeks +56.4% MD stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Pediatrix Medical Group’s (NYSE:MD) Q2 CY2026: Beats On Revenue But Stock Drops 12.3%

Pediatrix Medical Group (NYSE:MD) reported Q2 CY2026 results that exceeded revenue and non-GAAP profit expectations, with sales up 4% year-on-year to $487.8 million and adjusted EPS of $0.63. Despite beating estimates, the stock dropped 12.3% post-announcement, indicating investor disappointment. The company highlighted strong performance …

MD main company
Sharemaestro market context Trend signal active 52 weeks +56.4% MD stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Pediatrix Medical beats Q2 revenue estimates, reaffirms 2026 adjusted EBITDA outlook

Pediatrix Medical Group (NYSE: MD) reported Q2 revenue that beat analyst estimates, driven by recent acquisitions and improved reimbursement factors, despite a decrease in patient volumes. The company also reaffirmed its 2026 full-year Adjusted EBITDA outlook. Analysts currently rate the stock as a "buy" …

MD main company
Sharemaestro market context Trend signal active 52 weeks +56.4% MD stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Earnings Flash (MD) Pediatrix Medical Group, Inc. Posts Q2 Adjusted EPS $0.63 per Share, vs. FactSet Est of $0.59

Pediatrix Medical Group, Inc. (MD) reported Q2 adjusted EPS of $0.63 per share, surpassing FactSet's estimate of $0.59. The article provides a snapshot of the company's recent performance and mentions its Q2 2026 earnings call scheduled for August 4, 2026. Further details about the …

MD main company
Sharemaestro market context Trend signal active 52 weeks +56.4% MD stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Enterprise value to EBITDA forward of OneMedNet Corp – BOATS:ONMDW

This article provides financial data for OneMedNet Corp (BOATS:ONMDW), specifically focusing on its Enterprise Value to EBITDA forward metric. The information is presented within a financial charting platform context, highlighting the company's financial performance.

ONMD main company
Sharemaestro market context Price below Trend Line 52 weeks +0.1% · Next-week setup negative 42.5% ONMD stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Pediatrix Medical Group (MD) Q2 Earnings: What To Expect

Pediatrix Medical Group (MD) is set to report its Q2 earnings this Tuesday. The market expects a 1.9% year-on-year revenue growth, a turnaround from last year's decrease. The company has a strong track record of beating revenue estimates, and analysts have reconfirmed their expectations …

MD main company
Sharemaestro market context Trend signal active 52 weeks +56.4% MD stored weekly price path from 22 Aug 2025 to 14 Aug 2026

OneMedNet Corp Revenue Breakdown – BOATS:ONMDW

This article provides a revenue breakdown for OneMedNet Corp (ONMDW), highlighting its top contributing regions. The company's largest revenue segment came from Europe and the Middle East, generating $695,000 USD last year, a significant increase from $242,000 USD the previous year. The data presented …

ONMD main company
Sharemaestro market context Price below Trend Line 52 weeks +0.1% · Next-week setup negative 42.5% ONMD stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Price to sales forward of OneMedNet Corp – BOATS:ONMDW

This article provides financial information for OneMedNet Corp (ONMDW) focusing on its price to sales forward metric. The content is primarily a data display from TradingView, indicating that the market is closed with no trades. It is a very brief financial snapshot without detailed …

ONMD main company
Sharemaestro market context Price below Trend Line 52 weeks +0.1% · Next-week setup negative 42.5% ONMD stored weekly price path from 22 Aug 2025 to 14 Aug 2026

ONMD|Onemednet Corp|Price:0.715|Chg%:+0.073

This article provides a comprehensive overview of Onemednet Corp (ONMD), detailing its current market performance, financial indicators, and key insights. It highlights the company's strong growth in revenue and institutional ownership, while noting its stock is considered fairly valued and may trend downwards in …

ONMD main company
Sharemaestro market context Price below Trend Line 52 weeks +0.1% · Next-week setup negative 42.5% ONMD stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Onemednet Corp (ONMD) Technical Analysis: Support, Resistance, Indicators & Moving Averages

This article provides a technical analysis of Onemednet Corp (ONMD), focusing on its price momentum, support and resistance levels, and various technical indicators. It notes that ONMD's current price momentum score is 5.47, ranking 20th in its industry, and the stock is trading between …

ONMD main company
Sharemaestro market context Price below Trend Line 52 weeks +0.1% · Next-week setup negative 42.5% ONMD stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Pediatrix Medical Group Inc (MD) Technical Analysis: Support, Resistance, Indicators & Moving Averages

This article provides a technical analysis of Pediatrix Medical Group Inc (MD), focusing on its price momentum, support, resistance levels, and various technical indicators. It notes that MD's current stock price is trading between resistance at $28.32 and support at $24.25, suggesting suitability for …

MD main company
Sharemaestro market context Trend signal active 52 weeks +56.4% MD stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Pediatrix Medical Group Inc (MD) Risk Assessment: Volatility, Financial Risk & Investment Risk

This article provides a risk assessment for Pediatrix Medical Group Inc (MD), noting its current risk score of 5.98, ranking it 34 out of 75 in the Healthcare Providers & Services industry. The company has a beta value of 0.70, indicating it tends to …

MD main company
Sharemaestro market context Trend signal active 52 weeks +56.4% MD stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Pediatrix Medical Group Number of Employees 2026 | Employee Count & Headcount Data

Pediatrix Medical Group (NYSE: MD) had approximately 6,607 employees worldwide as of March 2026, marking a 3.3% decline from 2023 but a 0.1% increase year-over-year. The company is actively hiring, with 934 active job postings in 2026, a 46.9% increase from 2025. The workforce …

MD main company
Sharemaestro market context Trend signal active 52 weeks +56.4% MD stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Onemednet Corp (ONMD) Risk Assessment: Volatility, Financial Risk & Investment Risk

This article provides a risk assessment for Onemednet Corp. (ONMD), detailing its current risk score, industry ranking, and beta value. It further breaks down various risk metrics including maximum drawdown, volatility, Sharpe ratio, and liquidity indicators. The assessment notes the neutral effect of the …

ONMD main company
Sharemaestro market context Price below Trend Line 52 weeks +0.1% · Next-week setup negative 42.5% ONMD stored weekly price path from 22 Aug 2025 to 14 Aug 2026

OneMedNet Stock Rallies 33% After Hours: Here's Why

OneMedNet (NASDAQ: ONMD) shares surged 33% after hours following the announcement of an $11.5 million agreement to provide its iRWD™ imaging data platform for foundational AI model training. This deal validates the company's ability to deliver regulatory decision-grade Real-World Data at scale. The company's …

ONMD main company
Sharemaestro market context Price below Trend Line 52 weeks +0.1% · Next-week setup negative 42.5% ONMD stored weekly price path from 22 Aug 2025 to 14 Aug 2026

OneMedNet Secures $11.5+ Million Agreement to Supply Regulatory-Grade Real-World Data for Foundational AI Model Development

OneMedNet Corporation announced a significant agreement valued at over $11.5 million to supply its regulatory-grade Real-World Data (RWD) for the development and training of a foundational AI model. This deal validates OneMedNet's capabilities in providing high-quality, de-identified healthcare data, including millions of medical images …

ONMD main company
Sharemaestro market context Price below Trend Line 52 weeks +0.1% · Next-week setup negative 42.5% ONMD stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Find financial news

Search the Newsreel

Use one field or combine several. Results are newest first.

Evidence context